https://www.selleckchem.com/
The high failure rate in drug discovery remains a costly and time-consuming challenge. Improving the odds of success in the early steps of drug development requires disease models with high biological relevance for biomarker discovery and drug development. The adoption of three-dimensional (3D) cell culture systems over traditional monolayers in cell-based assays is considered a promising step toward improving the success rate in drug discovery. In this article, the author focuses on new technologies for 3D cell culture and their applications in cancer drug
Like
Comment
Share
